ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,098.07
0.33%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. TRxADE HEALTH Inc (MEDS)

  7. TRxADE HEALTH Inc (MEDS) Noticias

MEDS TRxADE HEALTH Inc

6.29
0.28 (4.66%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
TRxADE HEALTH Inc MEDS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.28 4.66% 6.29 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.02 6.02 6.42 6.29 6.01
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/4/202415:05GLOBETRxADE Health, Inc. Announces Receipt of Notice from Nasdaq..
06/3/202407:30EDGAR2Form 8-K - Current report
06/3/202407:05GLOBETRxADE Health, Inc. Announces Special Cash Dividend
26/2/202411:00EDGAR2Form SEC STAFF ACTION - SEC Staff Action: ORDER
16/2/202416:05EDGAR2Form 8-K - Current report
14/2/202413:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202408:07GLOBETrxade health, Inc files its 3Q 10Q
17/1/202408:05EDGAR2Form 8-K - Current report
16/1/202415:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/1/202405:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202416:25EDGAR2Form 8-K - Current report
29/11/202317:13GLOBETRxADE Announces Receipt of Notification of Deficiency from..
28/11/202311:29EDGAR2Form 8-K - Current report
15/11/202312:51EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
17/10/202307:05GLOBETrxADE Health, Inc. affirms its commitment to the..
13/10/202312:25EDGAR2Form 8-K - Current report
12/10/202307:05GLOBESuperlatus Announces Distribution Partnership with North..
11/10/202315:05EDGAR2Form 8-K - Current report
04/10/202308:29EDGAR2Form 8-K - Current report
04/10/202307:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Acquires the..
25/9/202307:06EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14/9/202316:28EDGAR2Form 8-K - Current report
08/9/202309:42EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
07/9/202307:05GLOBESuperlatus Announces Planned Expansion into Pet Food Market
25/8/202305:15EDGAR2Form 8-K - Current report
24/8/202308:47EDGAR2Form 8-K - Current report
24/8/202307:05GLOBESuperlatus Innovates $151 Billion US Snacking Market with..
22/8/202307:05GLOBESuperlatus, Newly Merged with TRxADE HEALTH, Agrees to..
18/8/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202309:25GLOBETRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
14/8/202307:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/8/202305:20EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202308:05GLOBENewly merged Entity Superlatus, Inc with Trxade Health, Inc...
31/7/202308:40EDGAR2Form 8-K - Current report
31/7/202307:35GLOBETRxADE HEALTH, Inc. Announces Closing of Acquisition of..
14/7/202316:08EDGAR2Form 425 - Prospectuses and communications, business..
14/7/202316:07EDGAR2Form 8-K - Current report
14/7/202315:30GLOBETRxADE HEALTH, Inc. Amends Definitive Merger Agreement with..
10/7/202315:58EDGAR2Form 8-K - Current report
30/6/202308:25EDGAR2Form 425 - Prospectuses and communications, business..
30/6/202308:25EDGAR2Form 8-K - Current report
30/6/202307:05GLOBESuperlatus, Inc. and TRxADE HEALTH, Inc. Sign Definitive..
27/6/202307:00GLOBESuperlatus, Inc. Announces New Appointments to the..
23/6/202315:40GLOBETRxADE HEALTH, Inc. Issues Correction to Press Release..
23/6/202307:05GLOBESuperlatus, Inc. to Combine with TRxADE HEALTH, Inc., to..
21/6/202311:36GLOBETRxADE Health, Inc.’s Board of Directors Approves Reverse..
15/5/202315:15GLOBETRxADE HEALTH Reports First Quarter Gross Margin of 69% and..

Su Consulta Reciente

NASDAQ
MEDS
TRxADE HEALTH
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados